Insider Transactions Reported by 25 Insiders of Roivant Sciences Ltd.

Symbol
ROIV on Nasdaq
Location
London

Insiders trading volume in the past year

Roivant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $1.06B 10 Nov 2022
Vivek Ramaswamy 10%+ Owner $1.01B -$160M -13.7% 11 Dec 2025
SVF Investments (UK) Ltd 10%+ Owner $756M 28 Sep 2023
Sumitomo Chemical Co., Ltd. 10%+ Owner $737M 22 Jun 2023
Mayukh Sukhatme President & CIO, Director $435M -$8.9M -2.01% 17 Dec 2025
KEITH MANCHESTER Director $379M -$65.4M -14.7% 16 Dec 2025
QVT Financial LP Director by Deputization $379M -$65.4M -14.7% 16 Dec 2025
Daniel Allen Gold Director $379M -$65.4M -14.7% 16 Dec 2025
Matthew Gline CEO, Director $375M -$37.7M -9.13% 15 Dec 2025
Eric Venker President & Immunovant CEO $154M -$96.9M -38.6% 09 Dec 2025
Frank Torti President and Vant Chair $149M 30 Jul 2025
VIKING GLOBAL INVESTORS LP 10%+ Owner $133M 22 Jun 2023
VIKING GLOBAL PERFORMANCE LLC 10%+ Owner $133M 22 Jun 2023
Benjamin Zimmer President, Roivant Health $12.1M 01 Oct 2021
Richard Pulik Cfo $8.65M 20 Dec 2025
Ilan Oren Director $2.1M 20 Oct 2025
JAMES C. MOMTAZEE Director $1.93M 20 Oct 2025
Rakhi Kumar Chief Accounting Officer $1.74M -$2.37M -57.7% 20 Feb 2025
Jennifer Humes Chief Accounting Officer $1.23M 20 Mar 2025
Melissa Epperly Director $861K 20 Oct 2025
Meghan Fitzgerald Director $592K 10 Sep 2025
Andrew Lo Director $540K 15 Sep 2022
Hiroshi Nomura Director 16 Sep 2022
Masayo Tada Director 01 Oct 2021
Patrick Machado Director 01 Oct 2021

Recent Insider Transactions by Companies or Individuals for Roivant Sciences Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.